Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Mar 2, 2011

Premium

Affymetrix said last week that Paul Berg will retire from its board of directors in May. Berg has been a board member of the company since its inception in 1993.


Olink Genomics has appointed a new chairman of the board and a chief business officer.

Mårten Winge
has been named chairman of the board, replacing Mats Nilsson as of October 2010. Nilsson will remain a member of the board. Previously, Winge served as CEO of Proxeon A/S, a company acquired by Thermo Fisher Scientific. Winge has 20 years of biotech tools industry experience, holding marketing and sales positions at various top life sciences firms.

Maria Hjortsmark has joined the company as its chief business officer. Previously, she was the senior brand manager at Phadia AB, which specializes in autoimmune disease diagnostics. Hjortsmark has over 20 years experience in product management, marketing and sales at companies such as Pharmacia Biotech and Pyrosequencing AB.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more